Employees Retirement System of Texas Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Employees Retirement System of Texas raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 33.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 877,272 shares of the exchange traded fund’s stock after purchasing an additional 220,400 shares during the period. Employees Retirement System of Texas’ holdings in SPDR S&P Biotech ETF were worth $79,007,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of XBI. Cerity Partners LLC raised its position in SPDR S&P Biotech ETF by 9.9% in the 4th quarter. Cerity Partners LLC now owns 17,589 shares of the exchange traded fund’s stock valued at $1,604,000 after purchasing an additional 1,590 shares during the last quarter. Himension Capital Singapore PTE. LTD. purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $2,160,000. Wedbush Securities Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 6.6% during the fourth quarter. Wedbush Securities Inc. now owns 6,582 shares of the exchange traded fund’s stock worth $593,000 after buying an additional 405 shares during the period. ExodusPoint Capital Management LP purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $6,027,000. Finally, World Investment Advisors acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $762,000.

SPDR S&P Biotech ETF Trading Down 5.7 %

SPDR S&P Biotech ETF stock opened at $73.66 on Monday. The stock has a 50 day moving average of $88.13 and a two-hundred day moving average of $93.12. SPDR S&P Biotech ETF has a twelve month low of $70.16 and a twelve month high of $105.47. The stock has a market capitalization of $4.65 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.